Loading...
Date of Award
Spring 2023
Degree Name
Master of Medical Science (Physician Assistant)
Department
Physician Assistant; College of Health Sciences
First Advisor
Kaitlyn Gamber
Abstract
Diagnosis of euglycemic diabetic ketoacidosis (euDKA) associated with the use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) poses a challenge for clinicians. The hyperglycemia that is a hallmark in the diagnosis of traditional DKA is not present in euDKA and this can lead to delayed diagnosis and worsen patient outcomes. It is necessary for healthcare providers to demonstrate an awareness of risk factors, signs, and symptoms associated with euDKA can expedite diagnosis. This article aims to highlight the prevention of SGLT2i-associated euDKA and to identify clinical findings to improve clinician diagnosis and subsequent management of euDKA in the surgical setting.
Recommended Citation
Myers, Kaylar, "Perioperative prevention, identification, and management of euglycemic DKA in patients taking SGLT-2 inhibitors" (2023). Capstone Showcase. 103.
https://scholarworks.arcadia.edu/showcase/2023/pa/103
Perioperative prevention, identification, and management of euglycemic DKA in patients taking SGLT-2 inhibitors
Diagnosis of euglycemic diabetic ketoacidosis (euDKA) associated with the use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) poses a challenge for clinicians. The hyperglycemia that is a hallmark in the diagnosis of traditional DKA is not present in euDKA and this can lead to delayed diagnosis and worsen patient outcomes. It is necessary for healthcare providers to demonstrate an awareness of risk factors, signs, and symptoms associated with euDKA can expedite diagnosis. This article aims to highlight the prevention of SGLT2i-associated euDKA and to identify clinical findings to improve clinician diagnosis and subsequent management of euDKA in the surgical setting.